Free Trial

Accuray (ARAY) Competitors

Accuray logo
$1.94 +0.07 (+3.74%)
(As of 01:00 PM ET)

ARAY vs. OFIX, SRDX, ANGO, RMTI, RSLS, ABT, ISRG, SYK, BSX, and MDT

Should you be buying Accuray stock or one of its competitors? The main competitors of Accuray include Orthofix Medical (OFIX), Surmodics (SRDX), AngioDynamics (ANGO), Rockwell Medical (RMTI), ReShape Lifesciences (RSLS), Abbott Laboratories (ABT), Intuitive Surgical (ISRG), Stryker (SYK), Boston Scientific (BSX), and Medtronic (MDT). These companies are all part of the "health care equipment" industry.

Accuray vs.

Accuray (NASDAQ:ARAY) and Orthofix Medical (NASDAQ:OFIX) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their profitability, community ranking, valuation, media sentiment, earnings, analyst recommendations, risk, institutional ownership and dividends.

Accuray has a net margin of -3.72% compared to Orthofix Medical's net margin of -15.18%. Orthofix Medical's return on equity of -21.25% beat Accuray's return on equity.

Company Net Margins Return on Equity Return on Assets
Accuray-3.72% -36.93% -3.52%
Orthofix Medical -15.18%-21.25%-13.29%

Accuray has higher earnings, but lower revenue than Orthofix Medical. Accuray is trading at a lower price-to-earnings ratio than Orthofix Medical, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Accuray$444.20M0.42-$15.55M-$0.17-10.96
Orthofix Medical$784.25M0.85-$151.40M-$3.13-5.55

64.1% of Accuray shares are owned by institutional investors. Comparatively, 89.8% of Orthofix Medical shares are owned by institutional investors. 4.2% of Accuray shares are owned by insiders. Comparatively, 2.6% of Orthofix Medical shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Orthofix Medical received 81 more outperform votes than Accuray when rated by MarketBeat users. However, 65.61% of users gave Accuray an outperform vote while only 61.92% of users gave Orthofix Medical an outperform vote.

CompanyUnderperformOutperform
AccurayOutperform Votes
332
65.61%
Underperform Votes
174
34.39%
Orthofix MedicalOutperform Votes
413
61.92%
Underperform Votes
254
38.08%

Accuray has a beta of 1.44, indicating that its share price is 44% more volatile than the S&P 500. Comparatively, Orthofix Medical has a beta of 1.09, indicating that its share price is 9% more volatile than the S&P 500.

Accuray currently has a consensus target price of $9.00, indicating a potential upside of 382.83%. Orthofix Medical has a consensus target price of $23.00, indicating a potential upside of 32.34%. Given Accuray's stronger consensus rating and higher possible upside, analysts plainly believe Accuray is more favorable than Orthofix Medical.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Accuray
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Orthofix Medical
0 Sell rating(s)
1 Hold rating(s)
3 Buy rating(s)
0 Strong Buy rating(s)
2.75

In the previous week, Accuray had 2 more articles in the media than Orthofix Medical. MarketBeat recorded 3 mentions for Accuray and 1 mentions for Orthofix Medical. Accuray's average media sentiment score of 0.41 beat Orthofix Medical's score of 0.38 indicating that Accuray is being referred to more favorably in the media.

Company Overall Sentiment
Accuray Neutral
Orthofix Medical Neutral

Summary

Accuray beats Orthofix Medical on 11 of the 18 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

ARAY vs. The Competition

MetricAccuraySurgical & medical instruments IndustryMedical SectorNASDAQ Exchange
Market Cap$187.45M$4.34B$5.18B$9.21B
Dividend YieldN/A44.59%5.12%4.30%
P/E Ratio-10.9624.8987.6517.17
Price / Sales0.4252.631,165.15121.16
Price / CashN/A43.4043.2337.84
Price / Book4.147.084.794.79
Net Income-$15.55M$13.64M$120.46M$225.43M
7 Day Performance-2.41%0.65%-0.97%-0.12%
1 Month Performance-3.42%-0.50%15.25%1.56%
1 Year Performance-35.05%39.04%29.71%16.07%

Accuray Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
ARAY
Accuray
4.5915 of 5 stars
$1.94
+3.7%
$9.00
+363.9%
-34.8%$195.10M$444.20M-11.41987
OFIX
Orthofix Medical
2.762 of 5 stars
$17.44
+0.1%
$23.00
+31.9%
+22.0%$666.45M$784.25M-5.571,634Positive News
SRDX
Surmodics
4.4098 of 5 stars
$39.59
-0.4%
$50.00
+26.3%
+7.0%$567.17M$126.08M-48.88376Positive News
ANGO
AngioDynamics
4.0623 of 5 stars
$8.64
-2.8%
$12.00
+38.9%
+11.3%$351.08M$292.73M-1.42748Gap Down
RMTI
Rockwell Medical
4.1373 of 5 stars
$2.12
+1.9%
$6.00
+183.0%
+11.6%$68.52M$98.92M-42.40300Analyst Forecast
RSLS
ReShape Lifesciences
0.8139 of 5 stars
$4.28
-2.3%
N/A-75.3%$3.05M$8.18M0.0050Positive News
Gap Up
ABT
Abbott Laboratories
4.8893 of 5 stars
$113.70
-0.5%
$130.71
+15.0%
+4.8%$197.21B$41.22B34.56114,000
ISRG
Intuitive Surgical
4.6136 of 5 stars
$522.62
-0.3%
$554.17
+6.0%
+56.8%$186.15B$7.87B84.0213,676
SYK
Stryker
4.952 of 5 stars
$366.07
+0.4%
$405.80
+10.9%
+23.2%$139.55B$21.97B39.2452,000
BSX
Boston Scientific
4.3381 of 5 stars
$89.70
+0.8%
$95.96
+7.0%
+60.8%$132.20B$15.91B74.1348,000
MDT
Medtronic
4.9454 of 5 stars
$80.99
0.0%
$95.00
+17.3%
-0.6%$103.85B$33.00B24.7795,000

Related Companies and Tools


This page (NASDAQ:ARAY) was last updated on 12/24/2024 by MarketBeat.com Staff
From Our Partners